发明名称 |
Device, array, and methods for disease detection and analysis |
摘要 |
A device and array coupled to capture molecules are provided. Specifically, the device and array can be used for detecting the presence and concentration of biomarkers in a sample from a subject. The device and array can also allow the use of a method for scoring a sample for, e.g., the purpose of diagnosing a disease. The method can also be advantageous to applications where there is a need to accurately determine the disease stage of a subject for the purpose of making therapeutic decisions. |
申请公布号 |
US9366668(B2) |
申请公布日期 |
2016.06.14 |
申请号 |
US201414465796 |
申请日期 |
2014.08.21 |
申请人 |
Lawrence Livermore National Security, LLC |
发明人 |
Rao Rupa S.;Lane Stephen M.;Matthews Dennis L.;Coleman Matthew A. |
分类号 |
G01N33/543;B01J19/00;C40B60/12;B01L3/00 |
主分类号 |
G01N33/543 |
代理机构 |
Fenwick & West, LLP |
代理人 |
Fenwick & West, LLP |
主权项 |
1. A multiplex immunoassay detection device for simultaneous measurement of a plurality of distinct breast cancer markers in a patient serum sample, comprising:
a glass solid support consisting of an array of antibody Clone 191924 for HER2, antibody Clone 36006.211 for MMP-2, antibody Clone M8071022 for CA-15-3 and antibody Clone 190312 for osteopontin; a glass cover plate, wherein the glass cover plate forms an upper surface positioned above the solid support; a vertical support comprising adhesive silicone, wherein the vertical support forms a connection between the solid support and the cover plate, the connection forming at least one channel surrounding the array of antibody Clone 191924 for HER2, antibody Clone 36006.211 for MMP-2, antibody Clone M8071022 for CA-15-3 and antibody Clone 190312 for osteopontin, and wherein the at least one channel comprises a first end and a second end and wherein the first end of the at least one channel comprises an opening; an absorbent material comprising a nitrocellulose membrane connected to the second end; and a set of biotinylated detection antibodies for detection of breast cancer markers bound to antibody Clone 191924 for HER2, antibody Clone 36006.211 for MMP-2, antibody Clone M8071022 for CA-15-3 and antibody Clone 190312 for osteopontin, the detection antibodies consisting of antibody clone AF-1129 for HER2, antibody clone AF-902 for MMP-2, antibody Clone M8071021 for CA 15-3 and antibody Clone AF-1433 for osteopontin. |
地址 |
Livermore CA US |